The WHO's "biological qualifier": voluntary or compulsory?
This article was originally published in Scrip
The deadline for stakeholders to comment on the World Health Organization's "biological qualifier" proposal has passed, and while submissions to date show a generally warm welcome for the idea, there are disagreements over how extensively it should be applied and whether it should be a voluntary or mandatory scheme.
You may also be interested in...
One effect of Brexit is that the UK’s National Institute for Biological Standards and Control will have additional responsibilities from next year in terms of the independent batch testing and release of products such as vaccines and medicines derived from human blood and plasma in Great Britain.
With the number of COVID-19 cases continuing to rise across Europe, the European Commission executive has published a set of actions to be taken at EU and national level to ensure future vaccines are allocated fairly, targeted at priority populations, and labeled in a way that increases production capacity, reduces transport costs and improves distribution.
A consultation on plans for the early availability of coronavirus vaccines drew almost 192,000 responses, including a number of concerns to which the government has now responded.